These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 25157919)

  • 1. Evaluation of the NucliSens EasyQ v2.0 assay in comparison with the Roche Amplicor v1.5 and the Roche CAP/CTM HIV-1 Test v2.0 in quantification of C-clade HIV-1 in plasma.
    Muenchhoff M; Madurai S; Hempenstall AJ; Adland E; Carlqvist A; Moonsamy A; Jaggernath M; Mlotshwa B; Siboto E; Ndung'u T; Goulder PJ
    PLoS One; 2014; 9(8):e103983. PubMed ID: 25157919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between the automated Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 assay and its version 1 and Nuclisens HIV-1 EasyQ version 2.0 assays when measuring diverse HIV-1 genotypes in China.
    Xu S; Song A; Nie J; Li X; Meng S; Zhang C; Wang Y
    J Clin Virol; 2012 Jan; 53(1):33-7. PubMed ID: 22051503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of NucliSens HIV-1 EasyQ Version 2.0 compared with six commercially available quantitative nucleic acid assays for detection of HIV-1 in China.
    Xu S; Song A; Nie J; Li X; Wang Y
    Mol Diagn Ther; 2010 Oct; 14(5):305-16. PubMed ID: 21053996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance evaluation of the new Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 for quantification of human immunodeficiency virus type 1 RNA.
    Pas S; Rossen JW; Schoener D; Thamke D; Pettersson A; Babiel R; Schutten M
    J Clin Microbiol; 2010 Apr; 48(4):1195-200. PubMed ID: 20164281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the bioMérieux NucliSENS EasyQ HIV-1 v2.0-HIV-1 RNA quantification assay versus Abbott RealTime HIV-1 and Roche Cobas TaqMan HIV-1 v2.0 on current epidemic HIV-1 variants.
    Mourez T; Delaugerre C; Vray M; Lemée V; Simon F; Plantier JC
    J Clin Virol; 2015 Oct; 71():76-81. PubMed ID: 26318912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 test v1.0 with v2.0 in HIV-1 viral load quantification.
    Tung YC; Ke LY; Lu PL; Lin KH; Lee SC; Lin YY; Chou LC; Tsai WC
    Kaohsiung J Med Sci; 2015 Apr; 31(4):188-93. PubMed ID: 25835274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction of underquantification of human immunodeficiency virus type 1 load with the second version of the Roche Cobas AmpliPrep/Cobas TaqMan assay.
    De Bel A; Marissens D; Debaisieux L; Liesnard C; Van den Wijngaert S; Lauwers S; Piérard D
    J Clin Microbiol; 2010 Apr; 48(4):1337-42. PubMed ID: 20164284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test and identification of rare polymorphisms potentially affecting assay performance.
    Pyne MT; Brown KL; Hillyard DR
    J Clin Microbiol; 2010 Aug; 48(8):2852-8. PubMed ID: 20573864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishing diagnostic cut-off criteria for the COBAS AmpliPrep/COBAS TaqMan HIV-1 Qualitative test through validation against the Amplicor DNA test v1.5 for infant diagnosis using dried blood spots.
    Maritz J; Preiser W; van Zyl GU
    J Clin Virol; 2012 Feb; 53(2):106-9. PubMed ID: 22196872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative performance of the Biocentric Generic Viral Load, Roche CAP/CTM v1.5, Roche CAP/CTM v2.0 and m2000 Abbott assays for quantifying HIV-1 B and non-B strains: Underestimation of some CRF02 strains.
    Avettand-Fénoël V; Mélard A; Gueudin M; Maillard A; Dina J; Gousset M; Chaix ML; Lerolle N; Viard JP; Meyer L; Plantier JC; Rouzioux C;
    J Clin Virol; 2019 Jan; 110():36-41. PubMed ID: 30530097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High correlation between the Roche COBAS® AmpliPrep/COBAS® TaqMan® HIV-1, v2.0 and the Abbott m2000 RealTime HIV-1 assays for quantification of viral load in HIV-1 B and non-B subtypes.
    Karasi JC; Dziezuk F; Quennery L; Förster S; Reischl U; Colucci G; Schoener D; Seguin-Devaux C; Schmit JC
    J Clin Virol; 2011 Nov; 52(3):181-6. PubMed ID: 21813320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of quantification of HIV-1 RNA viral load in plasma and dried blood spots by use of the semiautomated Cobas Amplicor assay and the fully automated Cobas Ampliprep/TaqMan assay, version 2.0, in Kisumu, Kenya.
    Ouma KN; Basavaraju SV; Okonji JA; Williamson J; Thomas TK; Mills LA; Nkengasong JN; Zeh C
    J Clin Microbiol; 2013 Apr; 51(4):1208-18. PubMed ID: 23390278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 (CAP/CTM v2.0) with other real-time PCR assays in HIV-1 monitoring and follow-up of low-level viral loads.
    Wojewoda CM; Spahlinger T; Harmon ML; Schnellinger B; Li Q; Dejelo C; Schmotzer C; Zhou L
    J Virol Methods; 2013 Jan; 187(1):1-5. PubMed ID: 23098667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial evaluation of the Roche COBAS TaqMan HIV-1 v2.0 assay for determining viral load in HIV-infected individuals.
    Taylor N; Schmid I; Egle A; Greil R; Patsch W; Oberkofler H
    Antivir Ther; 2009; 14(8):1189-93. PubMed ID: 20032549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of NucliSens EasyQ HIV-1 assay for quantification of HIV-1 subtypes prevalent in South-east Asia.
    Lam HY; Chen JH; Wong KH; Chan K; Li P; Lee MP; Tsang DN; Yuen KY; Yam WC
    J Clin Virol; 2007 Jan; 38(1):39-43. PubMed ID: 17110162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter evaluation of the NucliSens EasyQ HIV-1 v1.1 assay for the quantitative detection of HIV-1 RNA in plasma.
    de Mendoza C; Koppelman M; Montès B; Ferre V; Soriano V; Cuypers H; Segondy M; Oosterlaken T
    J Virol Methods; 2005 Jul; 127(1):54-9. PubMed ID: 15893566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Abbott m2000 RealTime human immunodeficiency virus type 1 (HIV-1) assay for HIV load monitoring in South Africa compared to the Roche Cobas AmpliPrep-Cobas Amplicor, Roche Cobas AmpliPrep-Cobas TaqMan HIV-1, and BioMerieux NucliSENS EasyQ HIV-1 assays.
    Scott LE; Noble LD; Moloi J; Erasmus L; Venter WD; Stevens W
    J Clin Microbiol; 2009 Jul; 47(7):2209-17. PubMed ID: 19420172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance evaluation of the new Roche cobas AmpliPrep/cobas TaqMan HCV test, version 2.0, for detection and quantification of hepatitis C virus RNA.
    Pas S; Molenkamp R; Schinkel J; Rebers S; Copra C; Seven-Deniz S; Thamke D; de Knegt RJ; Haagmans BL; Schutten M
    J Clin Microbiol; 2013 Jan; 51(1):238-42. PubMed ID: 23152551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of HIV-1 genetic diversity in China on the measurement of viral load.
    Wang Y; Song A; Xu S; Li X; Chong H; Zhao C; Nie J; Zhang C
    J Med Virol; 2008 Jan; 80(1):1-8. PubMed ID: 18041045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of dilution of plasma samples with phosphate buffered saline to eliminate the problem of small volumes associated with children infected with HIV-1 for viral load testing using Cobas AmpliPrep/COBAS TaqMan HIV-1 test, version 2.0 (CAP CTM HIV v2.0).
    Mine M; Nkoane T; Sebetso G; Sakyi B; Makhaola K; Gaolathe T
    J Virol Methods; 2013 Dec; 194(1-2):217-21. PubMed ID: 24025342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.